On Friday, May 8, 2020, the USPTO issued a release announcing a new COVID-19 Prioritized Examination Pilot Program, stating:
Under this new pilot program, the USPTO will grant requests for prioritized examination to applicants that qualify for small or micro entity status without payment of the typical fees[ of ~$2,000 and ~$1,000, respectively, ]associated with other prioritized examination. In addition, the USPTO will endeavor to reach final disposition of applications in this program within six months if applicants respond promptly to communications from the USPTO.
To qualify for the new program, the claims of an application must cover a product or process that is subject to U.S. Food and Drug Administration (FDA) approval for use in the prevention and/or treatment of COVID-19. See the Federal Register Notice for more information.
Please contact us if you have any questions regarding this item, noting that in light of the coronavirus pandemic, our office in Alexandria, Virginia has transitioned to teleworking in order to seamlessly continue the Firm's operations for our clients.